Cytokinetics Inc
(STU:KK3A)
€
50
1.4 (2.88%)
Market Cap: 5.86 Bil
Enterprise Value: 5.99 Bil
PE Ratio: 0
PB Ratio: 0
GF Score: 43/100 - Q1 2024 Cytokinetics Inc Earnings Call TranscriptMay 08, 2024€60.5 (+0.83%)Earnings
- Q4 2023 Cytokinetics Inc Earnings Call TranscriptFeb 27, 2024€73 (+4.29%)Earnings
- Cytokinetics Inc at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- Cytokinetics Inc to Discuss the Topline Results from SEQUOIA-HCM TranscriptDec 27, 2023
- Cytokinetics Inc at UBS BioPharma Conference TranscriptNov 08, 2023
- Q3 2023 Cytokinetics Inc Earnings Call TranscriptNov 02, 2023€32.4 (-1.22%)Earnings
- Cytokinetics Inc To Host Virtual Investor & Analyst Day TranscriptOct 19, 2023
- Cytokinetics Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 11, 2023
- Q2 2023 Cytokinetics Inc Earnings Call TranscriptAug 03, 2023€28.8 (-0.69%)Earnings
- Cytokinetics Inc at Goldman Sachs Healthcare Conference TranscriptJun 12, 2023
- Cytokinetics Inc at Jefferies Healthcare Conference TranscriptJun 08, 2023
- Cytokinetics Inc at JMP Securities Life Sciences Conference TranscriptMay 15, 2023
- Cytokinetics Inc Annual Shareholders Meeting TranscriptMay 10, 2023
- Q1 2023 Cytokinetics Inc Earnings Call TranscriptMay 04, 2023€35.2 (+4.76%)Earnings
- Cytokinetics Inc at Needham Healthcare Conference (Virtual) TranscriptApr 17, 2023
- Cytokinetics Inc To Discuss COURAGE-ALS Update Call TranscriptMar 31, 2023
- Cytokinetics Inc at Barclays Global Healthcare Conference TranscriptMar 15, 2023
- Cytokinetics Inc ACC.23 Conference Call TranscriptMar 06, 2023
- Q4 2022 Cytokinetics Inc Earnings Call TranscriptMar 01, 2023€40.4 (+0.50%)Earnings
- Cytokinetics Inc To Discuss Omecamtiv Mecarbil Regulatory Update Call TranscriptMar 01, 2023
- Cytokinetics Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Cytokinetics Inc FDA Advisory Committee for Omecamtiv Mecarbill Update Call TranscriptDec 14, 2022
- Q3 2022 Cytokinetics Inc Earnings Call TranscriptNov 03, 2022€42.2 (+0.48%)Earnings
- Cytokinetics Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2022
- Q2 2022 Cytokinetics Inc Earnings Call TranscriptAug 04, 2022€41.6 (+0.48%)Earnings
- Cytokinetics Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 13, 2022
- Cytokinetics Inc Annual Shareholders Meeting TranscriptMay 10, 2022
- Q1 2022 Cytokinetics Inc Earnings Call TranscriptMay 04, 2022€37.6 (-1.05%)Earnings
- Cytokinetics Inc at Barclays Global Healthcare Conference TranscriptMar 16, 2022
- Q4 2021 Cytokinetics Inc Earnings Call TranscriptFeb 24, 2022€26.8 (-9.46%)Earnings
- Cytokinetics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2022
- Cytokinetics Inc and Royalty Pharma Funding Agreements Call TranscriptJan 07, 2022
- Cytokinetics Inc and Ji Xing Pharmaceuticals Ltd Call to Discuss Announced Expansion of Collaboration TranscriptDec 20, 2021
- Q3 2021 Cytokinetics Inc Earnings Call TranscriptNov 03, 2021€29.6 (+1.37%)Earnings
- Cytokinetics Inc Analyst and Investor Day TranscriptOct 07, 2021
- Cytokinetics Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2021
- Cytokinetics Inc Call to Discuss the Full Results from REDWOOD-HCM TranscriptSep 13, 2021
- Q2 2021 Cytokinetics Inc Earnings Call TranscriptAug 05, 2021€25.2 (+2.44%)Earnings
- Cytokinetics Inc to Discuss Positive Topline Results of Redwood-HCM Call TranscriptJul 19, 2021
- Cytokinetics Inc at Raymond James Human Health Innovation Conference (Virtual) TranscriptJun 21, 2021
- Cytokinetics Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 09, 2021
- Cytokinetics Inc Annual Shareholders Meeting TranscriptMay 12, 2021
- Q1 2021 Cytokinetics Inc Earnings Call TranscriptMay 06, 2021€19.2 (-1.54%)Earnings
- Cytokinetics Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 11, 2021
- Q4 2020 Cytokinetics Inc Earnings Call TranscriptFeb 25, 2021€16.4 (-1.80%)Earnings
- Cytokinetics Inc Investor Event TranscriptNov 23, 2020
- Cytokinetics Inc GALACTIC-HF Investor/Media Event TranscriptNov 13, 2020
- Q3 2020 Cytokinetics Inc Earnings Call TranscriptNov 04, 2020€14.8 (+8.82%)Earnings
- Cytokinetics Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2020
- Q2 2020 Cytokinetics Inc Earnings Call TranscriptAug 06, 2020€18.6 (+1.09%)Earnings
- Cytokinetics Inc Virtual Analyst & Investor Day TranscriptJul 15, 2020
- Cytokinetics Inc Licensing Collaboration And Royalty Monetization Deals With RTW Investments Focused To CK-274 Corporate Call TranscriptJul 14, 2020
- Cytokinetics Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 10, 2020
- Cytokinetics Inc Annual Shareholders Meeting TranscriptMay 13, 2020
- Q1 2020 Cytokinetics Inc Earnings Call TranscriptMay 06, 2020€15 (+5.63%)Earnings
- Q4 2019 Cytokinetics Inc Earnings Call TranscriptMar 03, 2020€13.1 (+5.65%)Earnings
- Q3 2019 Cytokinetics Inc Earnings Call TranscriptOct 31, 2019€10.3Earnings
- Cytokinetics Inc at Morgan Stanley Healthcare Conference TranscriptSep 09, 2019
- Q2 2019 Cytokinetics Inc Earnings Call TranscriptAug 08, 2019€12.51 (+2.96%)Earnings
- Cytokinetics Inc at JMP Securities Life Science Conference TranscriptJun 19, 2019
- Cytokinetics Inc Annual Shareholders Meeting TranscriptMay 15, 2019
- Q1 2019 Cytokinetics Inc Earnings Call TranscriptMay 09, 2019€7.87 (-0.38%)Earnings
- Cytokinetics Inc Discusses Results from FORTITUDE-ALS TranscriptMay 06, 2019
- Cytokinetics Inc at Needham Healthcare Conference TranscriptApr 10, 2019
- Cytokinetics Inc at H C Wainwright Global Life Sciences Conference TranscriptApr 08, 2019
- Q4 2018 Cytokinetics Inc Earnings Call TranscriptFeb 21, 2019€6.45 (-2.57%)Earnings
Cytokinetics Inc at Barclays Global Healthcare Conference (Virtual) Transcript
Mar 11, 2021 / 02:45PM GMT
Release Date Price:
€16.9
(+0.60%)
Carter Lewis Gould
Barclays Bank PLC, Research Division - Senior Analyst
Good morning, and welcome to day 3 of the Barclays Global Healthcare Conference. My name is Carter Gould, senior biopharma analyst here at Barclays. I am pleased to welcome Cytokinetics to join me in the next virtual fireside chat. We recently initiated on the company, and they are entering a defining period with a key Phase II readout forthcoming on CK-274 while they're also beginning to gauge with regulators on omecamtiv after positive Phase III data late last year.
Joining -- representing the company is CEO, Robert Blum. Robert, welcome. Thanks for joining us. I believe you're going to start with some opening comments.
Robert I. Blum
Cytokinetics, Incorporated - CEO, President & Director
Yes. Thank you, Carter. Thanks for inviting us. I'll share my slides. Tell me if you can see that okay.
Carter Lewis Gould;Robert I. Blum
Barclays Bank PLC, Research Division - Senior Analyst;
Great.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)